Sign in
CompletedNo phase

Different Norepinephrine Doses on Accuracy of Peripheral Perfusion Index in Predicting Tissue Perfusion in Septic Shock Patients

Key facts

Who runs it
Tanta University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
80 people enrolled
Started
30 Oct 2024
Ended
30 Mar 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Group I: Patients will receive norepinephrine <0.15 µg/kg/min
  • Group II: Patients will receive norepinephrine ≥ 0.15 µg/kg/min
Record updated
9 January 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Age 18 to 65 years
  • Both sexes
  • Septic shock patients requiring norepinephrine infusion at dose <0.25 µg/kg/min to achieve mean arterial pressure (Mean arterial blood pressure ≥ 65 mm Hg)

Who cannot take part

  • Diabetes mellitus
  • Respiratory diseases affecting gas exchange, such as asthma and Chronic Obstructive Pulmonary Disease
  • Cardiovascular diseases and pulmonary edema
  • Patients fail to achieve Mean arterial blood ≥ 65 mm Hg or need norepinephrine dose ≥0.25 µg /kg/min
  • Pregnancy
  • Tissue edema
  • Sever hypoxemia or hypercarbia
  • Core temperature < 36 ᴼc
  • Body mass index ≥35 kg/m2

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the impact of different norepinephrine doses on the accuracy of the peripheral perfusion index in predicting tissue perfusion in septic shock patients.

Read full original descriptionShow less

Primary outcome:

* Correlation between peripheral perfusion index

Secondary outcomes:

* Peripheral perfusion index accuracy to predict the tissue perfusion . * Peripheral perfusion index accuracy to predict mortality.

The 2 groups in the trial

  • Group ITreatment being tested

    Patients will receive norepinephrine \<0.15 µg/kg/minute

    Treatment: Group I: Patients will receive norepinephrine <0.15 µg/kg/min

  • Group IITreatment being tested

    Patients will receive norepinephrine ≥ 0.15 µg/kg/minutes

    Treatment: Group II: Patients will receive norepinephrine ≥ 0.15 µg/kg/min

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Impact of Different Norepinephrine Doses on Accuracy of Peripheral Perfusion Index in Predicting Tissue Perfusion in Septic Shock Patients
Record updated
9 January 2026